ClinicalTrials.Veeva

Menu

A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands (REWARD)

Amgen logo

Amgen

Status

Completed

Conditions

Arthritis, Psoriatic

Study type

Observational

Funder types

Industry

Identifiers

NCT02875184
CC-10004-PSA-009-20200071 (Other Identifier)
CC-10004-PSA-009

Details and patient eligibility

About

This is a multicenter, prospective, non-interventional, observational single arm study.

100 patients will be recruited in the Netherlands over a one year period. In all cases, the decision to treat the patient with apremilast will be made prior to the decision to enter the subject into this study. Treatment will be according to routine clinical practice and based on recommendations as per the Summary of Product Characteristics (SPC) of apremilast (Otezla®). Each patient will be followed up for a maximum of 24 months.

Full description

The objective of this non-interventional study is to describe patient reported outcomes, effectiveness and real-life use of apremilast treatment in patients with psoriatic arthritis (PsA).

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criter

  • Patients ≥ 18 years of age who understand and voluntarily sign an informed consent form.
  • Patients starting treatment with apremilast for psoriatic arthritis.

Exclusion Criteria:

  • Refusal to participate in the study.
  • Language barrier for completing the questionnaires.
  • Women who are pregnant or breast-feeding.
  • Hypersensitivity to the active substance or to any of the excipients.
  • Prior exposure to apremilast
  • Initiation of apremilast treatment by a dermatologist for psoriasis

Trial design

200 participants in 1 patient group

Psoriatic arthritis patients treated with apremilast
Description:
Psoriatic arthritis patients who are treated with apremilast according to daily practice

Trial contacts and locations

21

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems